Pharma and biotech
Delivery modification, carrier evaluation and preclinical support for candidate molecules. Select suitable modules based on molecular properties, exposure objectives and development stage.
PARTNER WITH SHENGYU
Modular services, research collaboration and phased joint development for pharmaceutical companies, academic teams and clinical researchers.
WHO WE WORK WITH
Collaborate on a single technical question or jointly design a research pathway around a disease hypothesis.
Delivery modification, carrier evaluation and preclinical support for candidate molecules. Select suitable modules based on molecular properties, exposure objectives and development stage.
Carrier design, tailored characterization, cellular and animal studies. Controls and deliverables are planned around the research question and available resources.
Translate kidney or metabolic disease questions into carrier and model studies, beginning with testable mechanisms and preclinical endpoints.
WAYS TO COLLABORATE
Scope, milestones, fees and intellectual property are confirmed in a written agreement after project assessment.
Define a module’s starting point, methods, completion criteria and deliverables for projects with an established basis.
Define questions together and use milestone data to decide whether to continue, revise or stop exploratory work.
Discuss further development, ownership and collaboration once the technical basis, rights and resource requirements are clear.
START WITH A CLEAR BRIEF
Start with your research objective and existing evidence. Share unpublished structures, patient data or core technical details only after confidentiality arrangements are agreed.
Email us with your research goals and current starting point.
You can also download a project brief and send it as an email attachment.
FREQUENTLY ASKED QUESTIONS
Agree on research scope, technical stage, deliverables and confidentiality before starting a project.
Yes. We can discuss individual modules, defining existing evidence, methods and deliverables. The plan will explain interfaces between modules and relevant risks.
Begin with non-sensitive information on molecule type, target cells, objectives and existing data. Sample requirements, detailed technical information and confidentiality are addressed during further discussion.
This website presents research directions and preclinical services. Published work demonstrates scientific experience; it does not establish efficacy in kidney indications or imply product approval.
They are assessed in writing based on feasibility, study modules, samples, models, resources and deliverables. Indicative timelines support discussion and are not universal completion guarantees.
Project data, commissioned developments, existing background technology and future use are addressed separately in the contract. Licensing and joint development require specific agreements on rights.
No. The builder organizes information locally; copying or downloading is not a submission. “Copy brief & open email” attempts to open your email app, where you must review and send the message. You can also download the .txt file and email it to qixu19990421@gmail.com.